Dimethyl fumarate prevents acute lung injury related cognitive impairment potentially via reducing inflammation
Open Access
- 12 November 2021
- journal article
- research article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 16 (1) , 1-10
Abstract
Objective: Dimethyl fumarate (DMF) has been reported to exert a protective role against diverse lung diseases and cognitive impairment-related diseases. Thus this study aimed to investigate its role on acute lung injury (ALI) and related cognitive impairment in animal model. Methods: C57BL/6 mice were divided into four groups: control group, DMF group, ALI group, and ALI + DMF group. For ALI group, the ALI mice model was created by airway injection of LPS (50 μL, 1 μg/μL); for ALI + DMF group, DMF (dissolved in 0.08% methylcellulose) was treated twice a day for 2 days, and on the third day, mice were injected with LPS for ALI modeling. Mice pre-administered with methylcellulose or DMF without LPS injection (PBS instead) were used as the control group and DMF group, respectively. Morris water maze test was performed before any treatment (0 h) and 6 h after LPS-induction (54 h) to evaluate the cognitive impairment of mice. Next, the brain edema and blood brain barrier (BBB) permeability of ALI mice were assessed by brain water content, Evans blue extravasation and FITC-Dextran uptake assays. In addition, the effect of DMF on the numbers of total cells and neutrophils, protein content in BALF were quantified; the inflammatory factors in BALF, serum, and brain tissues were examined by ELISA, qRT-PCR, and Western blot assays. The effect of DMF on the cognitive impairment-related factor HIF-1α level in lung and brain tissues was also examined by Western blot. Results: DMF reduced the numbers of total cells, neutrophils and protein content in BALF of ALI mice, inhibited the levels of IL-6, TNF-α and IL-1β in BALF, serum and brain tissues of ALI mice. The protein expressions of p-NF-κB/NF-κB and p-IKBα/IKBα was also suppressed by DMF in ALI mice. Morris water maze test showed that DMF alleviated the cognitive impairment in ALI mice by reducing the escape latency and path length. Moreover, DMF lessened the BBB permeability by decreasing cerebral water content, Evans blue extravasation and FITC-Dextran uptake in ALI mice. The HIF-1α levels in lung and brain tissues of ALI mice were also lessened by DMF. Conclusion: In conclusion, DME had the ability to alleviate the lung injury and cerebral cognitive impairment in ALI model mice. This protective effect partly associated with the suppression of inflammation by DMF.Keywords
This publication has 43 references indexed in Scilit:
- Morris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model MiceJournal of Visualized Experiments, 2011
- Acute Lung Injury: Epidemiology, Pathogenesis, and TreatmentJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Inflammatory stimulation and hypoxia cooperatively activate HIF-1α in bronchial epithelial cells: involvement of PI3K and NF-κBAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- EFFECTS OF TNF-α-CONVERTING ENZYME INHIBITION ON ACUTE LUNG INJURY INDUCED BY ENDOTOXIN IN THE RATShock, 2009
- The role of redox‐dependent mechanisms in the downregulation of ligand‐induced Toll‐like receptors 7, 8 and 4‐mediated HIF‐1α prolyl hydroxylationImmunology & Cell Biology, 2009
- Valnemulin downregulates nitric oxide, prostaglandin E2, and cytokine production via inhibition of NF-κB and MAPK activityInternational Immunopharmacology, 2009
- Hypoxia-inducible Factor-1α Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate DepletionMolecular Biology of the Cell, 2008
- Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapiesJournal of Zhejiang University-SCIENCE B, 2007
- The Prevention of Lipopolysaccharide-induced Pulmonary Vascular Injury by Pretreatment with Cepharanthine in RatsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Experimental drug therapy of peritumoral brain edemaJournal of Neuro-Oncology, 1988